Skip to main content
. Author manuscript; available in PMC: 2022 Apr 4.
Published in final edited form as: Parkinsonism Relat Disord. 2019 Jan 31;62:201–209. doi: 10.1016/j.parkreldis.2018.12.025

Table 2.

Incidence of all LP-Related AEs at baseline based on LP procedure characteristics.

Variable All Subjects PD Subjects Healthy Controls SWEDD Subjects

AE No AE p-value AE No AE p-value AE No AE p-value AE No AE p-value
Age 0.1073 0.5752 0.1777 0.6316
 < 56 years 52 (27.23%) 139 (72.77%) 27 (23.68%) 87 (76.32%) 18 (32.73%) 37 (67.27%) 7 (31.82%) 15 (68.18%)
 56–65 years 56 (22.67%) 191 (77.33%) 29 (19.08%) 123 (80.92%) 21 (27.63%) 55 (72.37%) 6 (31.58%) 13 (68.42%)
 > 65 years 45 (18.67%) 196 (81.33%) 29 (18.71%) 126 (81.29%) 12 (18.46%) 53 (81.54%) 4 (19.05%) 17 (80.95%)
Gender 0.0004 0.1603 0.0038 0.0180
 Male 80 (18.18%) 360 (81.82%) 50 (18.12%) 226 (81.88%) 24 (19.05%) 102 (80.95%) 6 (15.79%) 32 (84.21%)
 Female 73 (30.54%) 166 (69.46%) 35 (24.14%) 110 (75.86%) 27 (38.57%) 43 (61.43%) 11 (45.83%) 13 (54.17%)
Type of Needle 0.0039 0.0060 0.0782 0.3473
 20g Quincke 19 (38.78%) 30 (61.22%) 14 (42.42%) 19 (57.58%) 3 (27.27%) 8 (72.73%) 2 (40.00%) 3 (60.00%)
 22g Quincke 20 (30.30%) 46 (69.70%) 12 (27.27%) 32 (72.73%) 6 (42.86%) 8 (57.14%) 2 (25.00%) 6 (75.00%)
 25g Quincke 1 (7.69%) 12 (92.31%) 0 (0.00%) 8 (100.0%) 1 (50.00%) 1 (50.00%) 0 (0.00%) 3 (100.0%)
 22g Sprotte 12 (18.75%) 52 (81.25%) 4 (10.26%) 35 (89.74%) 6 (28.57%) 15 (71.43%) 2 (50.00%) 2 (50.00%)
 24g Sprotte 92 (19.53%) 379 (80.47%) 51 (17.71%) 237 (82.29%) 32 (22.22%) 112 (77.78%) 9 (23.08%) 30 (76.92%)
 18g 4 (50.00%) 4 (50.00%) 1 (20.00%) 4 (80.00%) 2 (100.0%) 0 (0.00%) 1 (100.0%) 0 (0.00%)
 Unknown/Missing 5 (62.50%) 3 (37.50%) 3 (75.00%) 1 (25.00%) 1 (50.00%) 1 (50.00%) 1 (50.00%) 1 (50.00%)
Method of Collection 0.0857 0.3769 0.1713 0.5676
 Gravity 66 (25.58%) 192 (74.42%) 36 (22.09%) 127 (77.91%) 22 (31.88%) 47 (68.12%) 8 (30.77%) 18 (69.23%)
 Syringe Suction 82 (19.85%) 331 (80.15%) 46 (18.11%) 208 (81.89%) 28 (22.40%) 97 (77.60%) 8 (23.53%) 26 (76.47%)
 Unknown/Missing 5 (62.50%) 3 (37.50%) 3 (75.00%) 1 (25.00%) 1 (50.00%) 1 (50.00%) 1 (50.00%) 1 (50.00%)
Lumbar Puncture Site 0.2801 0.3671 0.3285 0.7516
 L2-L3 Interspace 7 (20.59%) 27 (79.41%) 4 (17.39%) 19 (82.61%) 1 (14.29%) 6 (85.71%) 2 (50.00%) 2 (50.00%)
 L3-L4 Interspace 93 (20.81%) 354 (79.19%) 47 (17.87%) 216 (82.13%) 34 (23.94%) 108 (76.06%) 12 (28.57%) 30 (71.43%)
 L4-L5 Interspace 41 (26.97%) 111 (73.03%) 25 (24.27%) 78 (75.73%) 14 (35.00%) 26 (65.00%) 2 (22.22%) 7 (77.78%)
 Unknown/Missing 12 (26.09%) 34 (73.91%) 9 (28.13%) 23 (71.88%) 2 (28.57%) 5 (71.43%) 1 (14.29%) 6 (85.71%)
Subject position during LP 0.0737 0.5083 0.1688 0.3495
 Sitting, leaned over 98 (23.56%) 318 (76.44%) 50 (19.84%) 202 (80.16%) 37 (29.60%) 88 (70.40%) 11 (28.21%) 28 (71.79%)
 Lying, curled up on side 41 (17.52%) 193 (82.48%) 25 (16.67%) 125 (83.33%) 13 (20.00%) 52 (80.00%) 3 (15.79%) 16 (84.21%)
 Unknown/Missing 14 (48.28%) 15 (51.72%) 10 (52.63%) 9 (47.37%) 1 (16.67%) 5 (83.33%) 3 (75.00%) 1 (25.00%)
CSF Hemoglobin 0.4815 0.8795 0.2845 0.4681
 < 200 ng/ml 115 (21.70%) 415 (78.30%) 66 (20.12%) 262 (79.88%) 37 (24.03%) 117 (75.97%) 12 (25.00%) 36 (75.00%)
 200 ng/ml or above 32 (24.62%) 98 (75.38%) 16 (19.05%) 68 (80.95%) 12 (34.29%) 23 (65.71%) 4 (36.36%) 7 (63.64%)
 Missing 6 (31.58%) 13 (68.42%) 3 (33.33%) 6 (66.67%) 2 (28.57%) 5 (71.43%) 1 (33.33%) 2 (66.67%)

Note: p-values come from Fisher’s Exact Tests.